Skip to main content
. 2023 Jul 20;58(10):947–964. doi: 10.1007/s00535-023-02021-7

Fig. 3.

Fig. 3

Old paradigm of attributing HCC to a single aetiology. In reality, there is substantial overlap between MAFLD-HCC with other liver diseases, yet little is known about the distinct mechanisms, outcomes and response to treatments in these “dual-aetiology” tumours. Adapted from [4]